Fluoxetine
Fluoxetine is a selective serotonin reuptake inhibitor prescribed to heal depression or obsessive-compulsive disorder in adults.
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 180 | $0.34 | $62.00 (0%) | 🛒 Add to cart |
| 360 | $0.31
Best per cap | $124.00 $111.00 (10%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.67 | $40.00 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $60.00 $54.00 (10%) | 🛒 Add to cart |
| 120 | $0.56 | $80.00 $67.00 (16%) | 🛒 Add to cart |
| 180 | $0.53 | $120.00 $95.00 (21%) | 🛒 Add to cart |
| 270 | $0.51 | $180.00 $137.00 (24%) | 🛒 Add to cart |
| 360 | $0.50
Best per cap | $240.00 $179.00 (25%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
Dapoxetine: Effective On-Demand Treatment for Premature Ejaculation
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSI) specifically developed and approved for the on-demand treatment of premature ejaculation (PE) in adult men. It represents a significant advancement in urological and sexual medicine, offering a pharmacologically targeted approach to a condition that affects a substantial portion of the male population. Unlike daily-dosed antidepressants sometimes used off-label, dapoxetine’s rapid absorption and elimination profile is uniquely suited for use prior to anticipated sexual activity.
Enclomisign: A Selective Estrogen Receptor Modulator for Testosterone Optimization
Enclomisign represents a significant advancement in the pharmacological management of male hypogonadism. As a selective estrogen receptor modulator (SERM) with a unique enantiomeric structure, it offers a targeted approach to stimulating endogenous testosterone production without the drawbacks associated with traditional testosterone replacement therapy (TRT). This non-steroidal agent works by competitively antagonizing estrogen receptors in the pituitary gland, thereby reducing negative feedback and increasing gonadotropin-releasing hormone (GnRH) pulsatility. The resulting elevation in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion promotes testicular Leydig cell function and spermatogenesis, making it particularly valuable for men seeking to preserve or restore fertility while addressing hypogonadal symptoms.
Kamagra Super: Dual-Action Erectile Dysfunction Treatment
Kamagra Super is a clinically formulated, dual-action oral medication designed to address both erectile dysfunction and premature ejaculation in adult men. Combining the proven vasodilatory effects of sildenafil citrate with the selective serotonin reuptake inhibition properties of dapoxetine, it offers a comprehensive approach to improving sexual performance and confidence. This medication is developed for those seeking a reliable, fast-acting solution that targets two of the most common sexual health concerns simultaneously.
Poxet: Clinically Proven Premature Ejaculation Management
Poxet represents a significant advancement in the pharmacological management of premature ejaculation (PE), offering men a reliable and well-tolerated treatment option. This product card provides a comprehensive, expert-level overview of Poxet, detailing its mechanism of action, appropriate usage, and essential safety information. It is formulated with dapoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI) specifically developed and approved for this indication, distinguishing it from antidepressants used off-label. Features Active Ingredient: Dapoxetine Hydrochloride.
Top Avana: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
Top Avana is a clinically validated, prescription-only combination medication designed to address two of the most prevalent male sexual health concerns concurrently: erectile dysfunction (ED) and premature ejaculation (PE). This advanced pharmaceutical formulation synergistically combines two well-established active ingredients—Avanafil and Dapoxetine—to deliver robust, reliable, and rapid therapeutic effects. By targeting the distinct physiological pathways underlying these conditions, Top Avana facilitates improved erectile function and significant prolongation of intravaginal ejaculatory latency time, thereby enhancing sexual performance, confidence, and overall satisfaction for men and their partners.
Abhigra: Advanced Treatment for Erectile Dysfunction
Abhigra is a clinically validated pharmaceutical agent designed to address erectile dysfunction (ED) with precision and reliability. Formulated with sildenafil citrate as its active ingredient, it functions by enhancing blood flow to the penile tissues, facilitating sustainable and satisfactory erections. This medication is intended for adult males experiencing difficulties in achieving or maintaining an erection sufficient for sexual activity. Supported by extensive research and adherence to stringent manufacturing standards, Abhigra offers a trusted solution for improving sexual health and quality of life.
Alprostadil: Restoring Natural Erections for Erectile Dysfunction
Alprostadil is a synthetic prostaglandin E1 analog used primarily in the treatment of erectile dysfunction (ED). As a vasodilator, it works by relaxing smooth muscle tissue and dilating cavernosal arteries, thereby increasing blood flow into the penis to facilitate an erection. This medication is available in several administration forms, including intracavernosal injection, intraurethral pellet, and topical cream, offering flexibility based on patient preference and clinical suitability. It represents a well-established, effective second-line therapy for men who do not respond to or cannot use oral phosphodiesterase type 5 inhibitors.
Androxal: Clinically Validated Testosterone Restoration Therapy
Androxal (enclomiphene citrate) represents a significant advancement in the treatment of male hypogonadism, specifically for men with secondary hypogonadism. Unlike traditional testosterone replacement therapies (TRT) which often suppress natural hormone production and can impair fertility, Androxal works through a novel mechanism of action. It stimulates the hypothalamic-pituitary-gonadal (HPG) axis to promote the body’s own endogenous testosterone production. This profile provides a comprehensive, evidence-based overview of its specifications, clinical application, and safety data for healthcare professionals.
Apcalis SX Oral Jelly: Fast-Acting Erectile Dysfunction Relief
Apcalis SX Oral Jelly is a specialized phosphodiesterase type 5 (PDE5) inhibitor formulated for the treatment of erectile dysfunction. It contains Tadalafil as its active pharmaceutical ingredient, delivered in a convenient, palatable oral jelly format for rapid absorption and predictable pharmacokinetics. This formulation is designed to offer a reliable therapeutic option with an onset of action typically within 15–30 minutes, supporting spontaneity and reducing planning-related anxiety. It is intended for adult male use under appropriate medical supervision.